Novel oral iron drug may be effective for anemic kidney disease patients
Researchers at Stanford University (Stanford, CA, USA) may have identified an alternative treatment for anemia in patients with chronic kidney disease with a new oral iron formulation.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.